SGSN Stock Analysis: SGS | SW
Consulting Services | SW, Switzerland | Market Cap: 19.057m CHF | 12M Return: 18.3% | CH1256740924 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 26.1M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
SGS SA is a Switzerland-based testing, inspection, and certification (TIC) company founded in 1878 and headquartered in Baar. It operates globally across Asia Pacific, Europe, North America, Eastern Europe, the Middle East, Africa, and the Americas, organized into two reporting segments: Testing & Inspection and Certification.
The company provides a broad range of services, including laboratory and field testing, pre-shipment and quality inspections, auditing, product and supply chain certification, sustainability and digital trust assurance, and professional training. Its customer base spans multiple end markets, such as agriculture, food, mining, oil and gas, pharma, MedTech, industrial manufacturing, and consumer products.
The TIC industry is characterized by long-standing third-party accreditation, recurring inspection and re-certification contracts, and demand tied to global trade, regulatory compliance, and product safety standards. SGS competes alongside other large international TIC providers, with revenue largely driven by volumes of goods traded, manufactured, or consumed across regulated industries.
- Testing and Inspection segment revenue grows on global trade recovery
- Sustainability certification demand boosts high-margin assurance services
- Acquisitions expand margins in MedTech and cybersecurity verticals
| Net Income: 663.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.15 > 1.0 |
| NWC/Revenue: -2.26% < 20% (prev 7.68%; Δ -9.94% < -1%) |
| CFO/TA 0.15 > 3% & CFO 1.25b > Net Income 663.0m |
| Net Debt (4.51b) to EBITDA (1.58b): 2.85 < 3 |
| Current Ratio: 0.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (196.0m) vs 12m ago 4.81% < -2% |
| Gross Margin: 37.25% > 18% (prev 39.43%; Δ -2.18% > 0.5%) |
| Asset Turnover: 92.08% > 50% (prev 71.98%; Δ 20.11% > 0%) |
| Interest Coverage Ratio: 10.69 > 6 (EBIT TTM 1.08b / Interest Expense TTM 101.0m) |
| A: -0.02 (Total Current Assets 3.22b - Total Current Liabilities 3.39b) / Total Assets 8.47b |
| B: 0.35 (Retained Earnings 3.00b / Total Assets 8.47b) |
| C: 0.14 (EBIT TTM 1.08b / Avg Total Assets 7.83b) |
| D: 0.14 (Book Value of Equity 1.01b / Total Liabilities 7.34b) |
| Altman-Z'' = 2.10 = BBB |
| DSRI: 0.89 (Receivables 1.55b/1.26b, Revenue 7.21b/5.17b) |
| GMI: 1.06 (GM 39.43% / 37.25%) |
| AQI: 1.29 (AQ_t 0.45 / AQ_t-1 0.35) |
| SGI: 1.39 (Revenue 7.21b / 5.17b) |
| TATA: -0.07 (NI 663.0m - CFO 1.25b) / TA 8.47b) |
| Beneish M = -2.62 (Cap -4..+1) = A |
As of October 15, 2026, the stock is trading at CHF 98.14 with a total of 352,631 shares traded. Over the past week, the price has changed by +4.54%, over one month by +6.01%, over three months by +3.92% and over the past year by +18.26%.
Current recommended Stop Loss: 95.40 (which is 2.8% or 2 ATR below the current price).
SGS has no consensus analysts rating.
P/E Trailing = 28.3647
P/E Forward = 21.8818
P/S = 2.6445
P/B = 18.5237
P/EG = 5.4756
Revenue TTM = 7.21b CHF
EBIT TTM = 1.08b CHF
EBITDA TTM = 1.58b CHF
Long Term Debt = 3.26b CHF (from longTermDebt, last quarter)
Short Term Debt = 1.52b CHF (from shortTermDebt, last quarter)
Debt = 5.81b CHF (from shortLongTermDebtTotal, last quarter) + Leases 590.0m
Net Debt = 4.51b CHF (calculated: Debt 5.81b - CCE 1.30b)
Enterprise Value = 23.6b CHF (19.1b + Debt 5.81b - CCE 1.30b)
Interest Coverage Ratio = 10.69 (Ebit TTM 1.08b / Interest Expense TTM 101.0m)
EV/FCF = 23.68x (Enterprise Value 23.6b / FCF TTM 995.0m)
FCF Yield = 4.22% (FCF TTM 995.0m / Enterprise Value 23.6b)
FCF Margin = 13.81% (FCF TTM 995.0m / Revenue TTM 7.21b)
Net Margin = 9.20% (Net Income TTM 663.0m / Revenue TTM 7.21b)
Gross Margin = 37.25% ((Revenue TTM 7.21b - Cost of Revenue TTM 4.52b) / Revenue TTM)
Gross Margin QoQ = 36.60% (prev 37.92%)
Tobins Q-Ratio = 2.78 (Enterprise Value 23.6b / Total Assets 8.47b)
Interest Expense / Debt = 1.74% (Interest Expense 101.0m / Debt 5.81b)
Taxrate = 25.13% (239.0m / 951.0m)
NOPAT = 808.6m (EBIT 1.08b * (1 - 25.13%))
Current Ratio = 0.95 (Total Current Assets 3.22b / Total Current Liabilities 3.39b)
Debt / Equity = 5.77 (Debt 5.81b / totalStockholderEquity, last quarter 1.01b)
Debt / EBITDA = 2.85 (Net Debt 4.51b / EBITDA 1.58b)
Debt / FCF = 4.53 (Net Debt 4.51b / FCF TTM 995.0m)
Total Stockholder Equity = 836.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.47% (Net Income 663.0m / Total Assets 8.47b)
RoE = 79.26% (Net Income TTM 663.0m / Total Stockholder Equity 836.5m)
RoCE = 26.34% (EBIT 1.08b / Capital Employed (Equity 836.5m + L.T.Debt 3.26b))
RoIC = 12.94% (NOPAT 808.6m / Invested Capital 6.25b)
WACC = 5.72% (E(19.1b)/V(24.9b) * Re(7.06%) + D(5.81b)/V(24.9b) * Rd(1.74%) * (1-Tc(0.25)))
Discount Rate = 7.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -40.44 | Cagr: 1.99%
[DCF] Terminal Value 77.97% ; FCFF base≈938.8m ; Y1≈1.08b ; Y5≈1.58b
[DCF] Fair Price = 97.82 (EV 23.8b - Net Debt 4.51b = Equity 19.3b / Shares 197.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -57.77 | EPS CAGR: -56.35% | SUE: 0.0 | # QB: 0
Revenue Correlation: -21.65 | Revenue CAGR: -3.26% | SUE: 1.13 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=4.13 | Chg30d=+0.38% | Revisions=+25% | GrowthEPS=+8.1% | GrowthRev=+9.6%
EPS next Year (2027-12-31): EPS=4.51 | Chg30d=+1.02% | Revisions=+25% | GrowthEPS=+9.1% | GrowthRev=+7.0%
[Analyst] Revisions Ratio: +40% (up=2, down=0)